Home › Dermatomyositis › Ohio
Dermatomyositis clinical trials in Ohio
5 studies for Dermatomyositis are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Cleveland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jul 27, 2026 · NCT07089121Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
- Cleveland Clinic, Cleveland
RecruitingPhase 2
Ages 18 to 89 · All sexes · Updated Oct 8, 2025 · NCT06857240From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.